These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31621546)

  • 1. Treatment of the antiphospholipid syndrome with direct oral anticoagulantsPosition statement of German societies.
    Bauersachs R; Langer F; Kalka C; Konstantinides S; Klamroth R; Oldenburg J; Schellong S; Scholz U; Stücker M; Lindhoff-Last E
    Vasa; 2019 Nov; 48(6):483-486. PubMed ID: 31621546
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?
    Arachchillage DRJ; Laffan M
    Br J Haematol; 2020 Apr; 189(2):216-227. PubMed ID: 32108324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
    Cohen H; Doré CJ; Clawson S; Hunt BJ; Isenberg D; Khamashta M; Muirhead N;
    Lupus; 2015 Sep; 24(10):1087-94. PubMed ID: 25940537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.
    Dufrost V; Risse J; Zuily S; Wahl D
    Curr Rheumatol Rep; 2016 Dec; 18(12):74. PubMed ID: 27812956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.
    Dufrost V; Risse J; Reshetnyak T; Satybaldyeva M; Du Y; Yan XX; Salta S; Gerotziafas G; Jing ZC; Elalamy I; Wahl D; Zuily S
    Autoimmun Rev; 2018 Oct; 17(10):1011-1021. PubMed ID: 30103045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
    Malec K; Góralczyk T; Undas A
    Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.
    Dufrost V; Wahl D; Zuily S
    Autoimmun Rev; 2021 Jan; 20(1):102711. PubMed ID: 33197580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
    Resseguier AS; Pereira B; Rieu V; Le Guenno G; Grobost V; Ruivard M
    Lupus; 2017 Oct; 26(12):1297-1303. PubMed ID: 28355988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome.
    Williams B; Saseen JJ; Trujillo T; Palkimas S
    J Thromb Thrombolysis; 2022 Jul; 54(1):67-73. PubMed ID: 34817786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of direct oral anticoagulants in antiphospholipid syndrome.
    Cohen H; Efthymiou M; Isenberg DA
    J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis.
    Sanchez-Redondo J; Espinosa G; Varillas Delgado D; Cervera R
    Clin Ther; 2019 Sep; 41(9):1839-1862. PubMed ID: 31405527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of the antiphospholipid syndrome.
    Chaturvedi S; McCrae KR
    Blood Rev; 2017 Nov; 31(6):406-417. PubMed ID: 28784423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS).
    Balbi GGM; Pacheco MS; Monticielo OA; Funke A; Danowski A; Santiago MB; Staub HL; Rêgo J; de Andrade DCO
    Adv Rheumatol; 2020 May; 60(1):29. PubMed ID: 32460902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of lupus anticoagulant in the era of direct oral anticoagulants.
    Hoxha A; Banzato A; Ruffatti A; Pengo V
    Autoimmun Rev; 2017 Feb; 16(2):173-178. PubMed ID: 27988438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct oral anticoagulants versus warfarin in patients with antiphospholipid syndrome: A meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Lupus; 2022 Oct; 31(11):1335-1343. PubMed ID: 35968627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A meta-analysis.
    Cerdà P; Becattini C; Iriarte A; Hernández JC; Corbella X; Riera-Mestre A
    Eur J Intern Med; 2020 Sep; 79():43-50. PubMed ID: 32482595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases.
    Signorelli F; Nogueira F; Domingues V; Mariz HA; Levy RA
    Clin Rheumatol; 2016 Mar; 35(3):801-5. PubMed ID: 26219490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct-acting oral anticoagulants in antiphospholipid syndrome: A systematic review.
    Girón-Ortega JA; Girón-González JA
    Med Clin (Barc); 2023 Jul; 161(2):65-77. PubMed ID: 37105842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials.
    Adelhelm JBH; Christensen R; Balbi GGM; Voss A
    Lupus Sci Med; 2023 Oct; 10(2):. PubMed ID: 37899090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis.
    Wu X; Cao S; Yu B; He T
    Blood Coagul Fibrinolysis; 2022 Oct; 33(7):389-401. PubMed ID: 35867933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.